Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Robert R. Conley
JCP
Article
Adverse Events Related to Olanzapine
JCP
Original Research
Analysis of Gene Variants Previously Associated With Iloperidone Response in Patients With Schizophrenia Who Are Treated With Risperidone
JCP
Article
The Application of Neuroimaging Techniques to Drug Development
JCP
Original Research
Cardiovascular Disease Mortality in Patients With Chronic Schizophrenia Treated With Clozapine: A Retrospective Cohort Study
JCP
Original Research
Clozapine Utilization and Outcomes by Race in a Public Mental Health System: 1994-2000
JCP
Original Research
A Dose-Outcome Analysis of Risperidone
JCP
Article
Evaluating Clinical Trial Data: Outcome Measures
JCP
Academic Highlights
Guidelines for the Use of Long-Acting Injectable Atypical Antipsychotics.
JCP
Article
Optimizing Treatment With Clozapine
JCP
Letter to the Editor
Overestimating the Prevalence of Subtherapeutic Dosing of Atypical Antipsychotics
JCP
Original Research
Pharmacogenomic Associations With Weight Gain in Olanzapine Treatment of Patients Without Schizophrenia
JCP
Original Research
Prevalence of Bone Mineral Density Loss in Korean Patients With Schizophrenia: A Cross-Sectional Study
JCP
Article
Risperidone Side Effects
JCP
Letter to the Editor
Six-Month Review of Weight and Metabolic Parameters in Patients Receiving Clozapine, Risperidone, Olanzapine, or Quetiapine
JCP
Original Research
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2003 Update
JCP
Original Research
The Texas Medication Algorithm Project Antipsychotic Algorithm for Schizophrenia: 2006 Update
JCP
Original Research
Thyroid Function in Treatment-Resistant Schizophrenia Patients Treated With Quetiapine, Risperidone, or Fluphenazine
JCP
Original Research
A Randomized Double-Blind Trial of Atomoxetine for Cognitive Impairments in 32 People With Schizophrenia